IMV INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMV INC and buy or sell other stocks, ETFs, and their options commission-free!About IMVIF
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response.
CEOAndrew Hall
CEOAndrew Hall
Employees—
Employees—
HeadquartersDartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded2007
Founded2007
Employees—
Employees—
IMVIF Key Statistics
Market cap1.17K
Market cap1.17K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume189.00
Average volume189.00
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0195
52 Week high$0.0195
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
IMV INC(IMVIF) stock is priced at $0.00, giving the company a market capitalization of 1.17K.
IMV INC(IMVIF) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.
IMV INC(IMVIF) shares are trading with a volume of 0, against a daily average of 189.
In the last year, IMV INC(IMVIF) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.
In the last year, IMV INC(IMVIF) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own IMVIF. This list is generated using Robinhood data, and it’s not a recommendation.